SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-019809
Filing Date
2022-05-18
Accepted
2022-05-18 17:13:36
Documents
4
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A edge20003960x2_def14a.htm DEF 14A 544418
2 edge20003960x2_pc1.jpg GRAPHIC 594890
3 edge20003960x2_pc2.jpg GRAPHIC 443866
4 logo_neurobo.jpg GRAPHIC 42967
  Complete submission text file 0001140361-22-019809.txt   2034487
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37809 | Film No.: 22940156
SIC: 2834 Pharmaceutical Preparations